These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3154374)

  • 1. Cyclosporine "rescue".
    Danovitch G
    Clin Transpl; 1986; ():123. PubMed ID: 3154374
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of chronic rejection by cyclosporine and prednisone.
    Arnold AN; Anaise D; Miller F; Waltzer WC; Rapaport FT
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2122-3. PubMed ID: 3274479
    [No Abstract]   [Full Text] [Related]  

  • 3. Antilymphoblast globulin treatment of steroid-resistant rejection in cyclosporine-immunosuppressed renal transplant recipients.
    Tellis VA; Matas AJ; Quinn TA; Glicklich D; Weiss RJ; Soberman RJ; Veith FJ
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1892. PubMed ID: 3274447
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of donor specific transfusion and cyclosporine A on graft outcome.
    Haberal M; Oner Z; Aybasti N; Arslan G; Turan M; Bilgin N
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2269-70. PubMed ID: 3274506
    [No Abstract]   [Full Text] [Related]  

  • 5. Rescue of severe steroid-resistant rejection with OKT3.PAN.
    Ponticelli C; Rivolta E; Tarantino A; De Vecchi A; Vegeto A
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1908-9. PubMed ID: 3274449
    [No Abstract]   [Full Text] [Related]  

  • 6. Renal transplantation in presensitized patients treated with cyclosporine.
    Albrechtsen D; Lundgren G; Bratlie A; Brynger H; Fehrmann I; Frödin L; Gäbel H; Lindholm A; Flatmark A
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1862. PubMed ID: 3274442
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of antithymocyte globulin and cyclosporine to treat steroid-resistant rejection episodes in renal transplant recipients.
    Benvenisty AI; Tannenbaum GA; Cohen DJ; Appel G; Hardy MA
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1889-91. PubMed ID: 3274446
    [No Abstract]   [Full Text] [Related]  

  • 8. Lymphocyte subpopulations in renal biopsies of transplant patients treated with cyclosporine.
    Lloveras J; Munne A; Serrano S; Corominas JM; Cuevas X; Masramon J
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1660-1. PubMed ID: 3274400
    [No Abstract]   [Full Text] [Related]  

  • 9. Conversion from azathioprine and/or prednisolone to cyclosporine A in renal allograft recipients.
    Ebel H; Lange H
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2005-6. PubMed ID: 3274463
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful use of cyclosporine in renal grafts with prolonged ischemic times.
    Chang RW; Saltissi D; al Khader Aa; Abomelha M; Jawdat M
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2080. PubMed ID: 3274473
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunosuppression with cyclosporine, azathioprine, and prednisolone in cadaver renal allograft recipients.
    Jones RM; Murie JA; Allen R; Jaskowski A; Morris PJ
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1926. PubMed ID: 3274453
    [No Abstract]   [Full Text] [Related]  

  • 12. T cell subset analysis predicts virus infection but not rejection in cyclosporine A-treated renal allograft recipients.
    Metselaar HJ; Jeekel J; Rothbarth PH; Vaessen LM; Wenting GJ; Weimar W
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2181-2. PubMed ID: 3274486
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of HLA-DR and combined HLA-B and HLA-DR matching on early graft outcome under cyclosporine therapy.
    Vanrenterghem Y; Roels L; Waer M; Gruwez J; Dendievel J; Michielsen P
    Transplant Proc; 1987 Feb; 19(1 Pt 1):685-6. PubMed ID: 3274841
    [No Abstract]   [Full Text] [Related]  

  • 14. Corticosteroid withdrawal with substitution of azathioprine in cyclosporine-treated primary cadaveric renal transplant recipients.
    Kupin W; Venkat KK; Florence-Green D; Norris C; Oh HK; Dienst S; Levin NW
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2024-6. PubMed ID: 3274465
    [No Abstract]   [Full Text] [Related]  

  • 15. Safe conversion from cyclosporine.
    Adams PL; Burkart JM; Hamilton RW; Lorentz WB; Browning MC; Meredith JH; Heise ER
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2010-1. PubMed ID: 3274464
    [No Abstract]   [Full Text] [Related]  

  • 16. Primary cadaveric renal transplantation using cyclosporine in patients over fifty years of age.
    Mandelbaum DM; Henry ML; Sommer BG; Ferguson RM
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1863-4. PubMed ID: 3274443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The differentiation of acute renal allograft rejection and cyclosporine nephrotoxicity by simple urine cytology.
    Williamson EP; Millar RJ; Criddle RA; Sells RA
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1785-6. PubMed ID: 3274423
    [No Abstract]   [Full Text] [Related]  

  • 18. Prolonged cyclosporine therapy to induce solid engraftment after renal transplantation.
    Weimar W; Versluis DJ; Wenting GJ; Derkx FH; Schalekamp MA; Jeekel J
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1998-9. PubMed ID: 3274462
    [No Abstract]   [Full Text] [Related]  

  • 19. Cadaveric renal transplantation in the cyclosporine and OKT3 eras: the University of Wisconsin-Madison experience.
    Stratta RJ; Armbrust MJ; Lorentzen DF; Hoffman RM; D'Alessandro AM; Sollinger HW; Pirsch JD; Kalayoglu M; Belzer FO
    Clin Transpl; 1987; ():183-93. PubMed ID: 3154400
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of HLA matching and panel reactive antibodies in the development of rejection after conversion of cyclosporine to azathioprine.
    Zemel SM; Shen SY; Weir MR; Dagher FJ; Bentley FR
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2029-31. PubMed ID: 3274466
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.